Clinical Trials Browser

Phase 2 × Neoplasms, Unknown Primary × Erlotinib Hydrochloride × Clear all

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT00360360 2013-12-04

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Phase 2 Completed

60 enrolled 6 charts

Neoplasms, Unknown Primary